287 related articles for article (PubMed ID: 26420364)
1. Vascular Biomarkers in Asthma and COPD.
Bakakos P; Patentalakis G; Papi A
Curr Top Med Chem; 2016; 16(14):1599-609. PubMed ID: 26420364
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic perspectives in vascular remodeling in asthma and chronic obstructive pulmonary disease.
Olivieri D; Chetta A
Chem Immunol Allergy; 2014; 99():216-25. PubMed ID: 24217612
[TBL] [Abstract][Full Text] [Related]
3. Aryl hydrocarbon receptor agonists upregulate VEGF secretion from bronchial epithelial cells.
Tsai MJ; Wang TN; Lin YS; Kuo PL; Hsu YL; Huang MS
J Mol Med (Berl); 2015 Nov; 93(11):1257-69. PubMed ID: 26076680
[TBL] [Abstract][Full Text] [Related]
4. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.
Kranenburg AR; de Boer WI; Alagappan VK; Sterk PJ; Sharma HS
Thorax; 2005 Feb; 60(2):106-13. PubMed ID: 15681497
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD.
Hashimoto M; Tanaka H; Abe S
Chest; 2005 Mar; 127(3):965-72. PubMed ID: 15764783
[TBL] [Abstract][Full Text] [Related]
6. Role of Inhaled Steroids in Vascular Airway Remodelling in Asthma and COPD.
Chetta A; Olivieri D
Int J Endocrinol; 2012; 2012():397693. PubMed ID: 23093959
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor as a key inducer of angiogenesis in the asthmatic airways.
Meyer N; Akdis CA
Curr Allergy Asthma Rep; 2013 Feb; 13(1):1-9. PubMed ID: 23076420
[TBL] [Abstract][Full Text] [Related]
8. The role of the bronchial microvasculature in the airway remodelling in asthma and COPD.
Zanini A; Chetta A; Imperatori AS; Spanevello A; Olivieri D
Respir Res; 2010 Sep; 11(1):132. PubMed ID: 20920222
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis and remodeling of airway vasculature in chronic inflammation.
McDonald DM
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S39-45. PubMed ID: 11734465
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular remodelling markers in relation to bradykinin receptors in asthma and COPD.
Ricciardolo FL; Sabatini F; Sorbello V; Benedetto S; Defilippi I; Petecchia L; Usai C; Gnemmi I; Balbi B; De Rose V; Ten Hacken NH; Postma DS; Timens W; Di Stefano A
Thorax; 2013 Sep; 68(9):803-11. PubMed ID: 23739138
[TBL] [Abstract][Full Text] [Related]
11. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.
Lai H; Rogers DF
J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774
[TBL] [Abstract][Full Text] [Related]
12. Statins in the treatment of COPD and asthma-where do we stand?
So JY; Dhungana S; Beros JJ; Criner GJ
Curr Opin Pharmacol; 2018 Jun; 40():26-33. PubMed ID: 29334676
[TBL] [Abstract][Full Text] [Related]
13. Characterization of sputum biomarkers for asthma-COPD overlap syndrome.
Gao J; Iwamoto H; Koskela J; Alenius H; Hattori N; Kohno N; Laitinen T; Mazur W; Pulkkinen V
Int J Chron Obstruct Pulmon Dis; 2016; 11():2457-2465. PubMed ID: 27757028
[TBL] [Abstract][Full Text] [Related]
14. New Anti-Eosinophil Drugs for Asthma and COPD: Targeting the Trait!
Bel EH; Ten Brinke A
Chest; 2017 Dec; 152(6):1276-1282. PubMed ID: 28583618
[TBL] [Abstract][Full Text] [Related]
15. Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease.
Lee CG; Ma B; Takyar S; Ahangari F; Delacruz C; He CH; Elias JA
Proc Am Thorac Soc; 2011 Nov; 8(6):512-5. PubMed ID: 22052929
[TBL] [Abstract][Full Text] [Related]
16. Spatial and phenotypic characterization of vascular remodeling in a mouse model of asthma.
Su X; Taniuchi N; Jin E; Fujiwara M; Zhang L; Ghazizadeh M; Tashimo H; Yamashita N; Ohta K; Kawanami O
Pathobiology; 2008; 75(1):42-56. PubMed ID: 18334839
[TBL] [Abstract][Full Text] [Related]
17. [The effect of a vascular endothelial growth factor receptor inhibitor on airway inflammation and airway remodeling in a murine model of asthma].
Wang ZH; Lin JT; Nong Y; Zhou TL
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Nov; 28(11):755-9. PubMed ID: 16324270
[TBL] [Abstract][Full Text] [Related]
18. Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD.
Kistemaker LE; Oenema TA; Meurs H; Gosens R
Life Sci; 2012 Nov; 91(21-22):1126-33. PubMed ID: 22406302
[TBL] [Abstract][Full Text] [Related]
19. Progress in the development of kinase inhibitors for treating asthma and COPD.
McClean N; Hasday JD; Shapiro P
Adv Pharmacol; 2023; 98():145-178. PubMed ID: 37524486
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic perspectives in bronchial vascular remodeling in COPD.
Zanini A; Chetta A; Olivieri D
Ther Adv Respir Dis; 2008 Jun; 2(3):179-87. PubMed ID: 19124370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
